Nano X Imaging Ltd (NNOX) Actualités

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Nanox.ARC Imaging System Receives FDA Clearance for General Use, Including Pulmonary Indication

Nanox.ARC receives additional FDA clearance to produce tomographic images for general use, including pulmonary...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Nanox Announces Third Quarter of 2024 Financial Results and Provides Business Update

Made progress deploying all components of the Nanox solution including Nanox.ARC and Nanox.AI Expanded US...

Nanox to Report Third Quarter and Financial Results on November 21, 2024

PETACH TIKVA, Israel, Nov. 11, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq:...

Nanox Highlighted on TIME's Best Inventions of 2024 List for its AI Solutions

Nanox AI’s Solutions selected for Special Mention on annual list recognizing the most impactful new products...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Nanox to Participate in Upcoming Investor Conference in September 2024

PETACH TIKVA, Israel, Sept. 10, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,”...

Nanox Receives FDA Clearance for HealthCCSng V2.0, Upgraded Version of Advanced AI Cardiac Solution Empowering Physicians in Assessment of Coronary Artery Calcium

HealthCCSng V2.0 introduces additional ‘zero calcium’ categorization of coronary artery calcium (CAC) and...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Nanox Announces Second Quarter of 2024 Financial Results and Provides Business Update

Accelerated the deployment of Nanox ARC in the US market, Submitted a new 510k application to the FDA to...